Armata Pharmaceuticals (ARMP) P/E (2014 - 2026)
Armata Pharmaceuticals (ARMP) P/E from Mar 31, 2014 to Jul 21, 2026. The TTM Armata Pharmaceuticals (ARMP) P/E is -0.66. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Armata Pharmaceuticals (ARMP)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.66 | -49.51% |
| 2025 | -1.32 | -62.75% |
| 2024 | -3.53 | +79.67% |
| 2023 | -1.97 | +52.16% |
| 2022 | -1.29 | -78.56% |
| 2021 | -6.03 | +140.13% |
| 2020 | -2.51 | +31.23% |
| 2019 | -1.91 | -42.80% |
| 2018 | -3.35 | -12.03% |
| 2017 | -3.80 | -55.21% |
| 2016 | -8.49 | -113.32% |
| 2015 | 63.78 | -18.87% |
| 2014 | 78.61 | N/A |
Comparison Armata Pharmaceuticals (ARMP) P/E with competitors
Armata Pharmaceuticals (ARMP) P/E is -0.66.